European Commission approves Orfadin oral suspension
29 June 2015 | By Victoria White
The European Commission (EC) has approved the oral suspension formulation of Sobi’s Orfadin for the treatment of Hereditary Tyrosinaemia type-1 (HT-1)...
List view / Grid view
29 June 2015 | By Victoria White
The European Commission (EC) has approved the oral suspension formulation of Sobi’s Orfadin for the treatment of Hereditary Tyrosinaemia type-1 (HT-1)...
29 June 2015 | By Victoria White
The Committee for Medicinal Products for Human Use (CHMP) has recommended granting marketing authorisation in the EU for CSL Behring's Respreeza...
29 June 2015 | By Victoria White
The CHMP has recommended that the EC approves the use of Perjeta for the neoadjuvant treatment of adult patients with HER2-positive early breast cancer...
29 June 2015 | By Victoria White
New one year results from the pivotal Phase III FUTURE 2 study of Novartis’ secukinumab in psoriatic arthritis (PsA) have been published.
29 June 2015 | By Victoria White
Novartis has entered into an agreement to acquire Spinifex - a company focused on developing a peripheral approach to treat neuropathic pain...
29 June 2015 | By Victoria White
The CHMP has issued a positive opinion for the expanded use of Novo Nordisk’s Levemir (insulin detemir) in children with diabetes as young as one year old...
26 June 2015 | By Victoria White
Alexion has announced that the CHMP of the EMA has adopted positive opinions recommending marketing authorisation of Strensiq and Kanuma...
26 June 2015 | By Victoria White
The CHMP of the EMA have adopted a positive opinion for panobinostat capsules for the treatment of patients with multiple myeloma...
26 June 2015 | By Victoria White
Biogen and SOBI have announced that the European Medicines Agency (EMA) has accepted the Marketing Authorisation Application (MAA) for Alprolix...
26 June 2015 | By Sartorius
Sartorius, a leading international laboratory and pharmaceutical equipment supplier, introduces a completely new concept for packaging pipette tips: FlexiBulk...
26 June 2015 | By Sartorius Stedim Biotech (SSB)
Sartorius Stedim Biotech (SSB), a leading international supplier for the biopharmaceutical industry, has introduced Sartoclear Dynamics®, a clarification system featuring new single-use technology for harvesting mammalian cell cultures with high cell densities...
26 June 2015 | By Victoria White
CHMP has recommended granting marketing authorisation to Raxone for the treatment of visual impairment in patients with Leber's Hereditary Optic Neuropathy...
26 June 2015 | By Victoria White
Immune Pharmaceuticals has initiated a Phase II trial of bertilimumab in ulcerative colitis and will initiate a Phase II bullous pemphigoid trial in July...
26 June 2015 | By Victoria White
The number of deals in the global gene therapy market more than doubled in 2014, with their combined value rising spectacularly to $4.9...
26 June 2015 | By Victoria White
The EC has approved Simponi (golimumab) for the treatment of adult patients with severe, active non-radiographic axial spondyloarthritis (nr-axial SpA)...